Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
10/27/2009 | US7608601 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication |
10/27/2009 | US7608597 For therapy and prophylaxis of a Hepatitis C virus infection in a host |
10/27/2009 | US7608452 Polynucleotides encoding cytokine receptor zcytor19 |
10/27/2009 | US7608284 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli |
10/27/2009 | US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
10/27/2009 | US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
10/27/2009 | US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy |
10/27/2009 | CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists |
10/27/2009 | CA2435426C Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
10/27/2009 | CA2422210C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
10/27/2009 | CA2421826C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
10/27/2009 | CA2419666C Colonic motor dysfunction remedies |
10/27/2009 | CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
10/27/2009 | CA2392057C Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same |
10/27/2009 | CA2381165C Novel quinuclidine derivatives and medicinal compositions containing the same |
10/27/2009 | CA2379021C New phenylpiperazines |
10/27/2009 | CA2376355C N-heterocyclic derivatives as nos inhibitors |
10/27/2009 | CA2365204C Lipoxin compounds and their use |
10/27/2009 | CA2338141C Polymer complexes of glucuronoglucanes |
10/22/2009 | WO2009128955A1 Treatment of inflammatory bowel disease with 6-mercaptopurine |
10/22/2009 | WO2009128558A1 Activator for peroxisome proliferator-activated receptor |
10/22/2009 | WO2009128523A1 Immunostimulating agent |
10/22/2009 | WO2009128481A1 Nitrogenated 5-membered heterocyclic compound |
10/22/2009 | WO2009128395A1 Bone formation promoter comprising 2-aminophenol or derivative thereof as active ingredient |
10/22/2009 | WO2009128383A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND |
10/22/2009 | WO2009128279A1 Composition for oral ingestion |
10/22/2009 | WO2009128262A1 Quinolone derivative and use thereof |
10/22/2009 | WO2009127283A1 Use of a composition containing healing earth as an antacid |
10/22/2009 | WO2009127140A1 7p peptide and its derivant, the use thereof |
10/22/2009 | WO2009127060A1 Novel lipid formulations for nucleic acid delivery |
10/22/2009 | WO2009108383A3 Substituted xanthine derivatives |
10/22/2009 | WO2009080351A9 Compounds with anti-emetic effect |
10/22/2009 | US20090264624 Human cytokine receptor |
10/22/2009 | US20090264515 Polynucleotide therapy |
10/22/2009 | US20090264507 Method of diagnosing gum disease-wound healing using single nucleotide polymorphism profiles |
10/22/2009 | US20090264441 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives |
10/22/2009 | US20090264433 Compounds, Compositions and Methods Comprising Triazine Derivatives |
10/22/2009 | US20090264424 Vanilloid receptor ligands and their use in treatments |
10/22/2009 | US20090264386 Mesalamine suppository |
10/22/2009 | US20090264384 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof |
10/22/2009 | US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications |
10/22/2009 | US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
10/22/2009 | US20090263490 Microsphere beeswax for mammalian dietary fat mitigation |
10/22/2009 | US20090263482 Treatment of inflammatory bowel disease with 6-mercaptopurine |
10/22/2009 | US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
10/22/2009 | US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection |
10/22/2009 | US20090263372 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same |
10/22/2009 | US20090263366 Effects of probiotics on humans and animals under environmental or biological changes |
10/22/2009 | US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines |
10/22/2009 | DE102008019339A1 Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum A composition for medical use, in particular antacid |
10/22/2009 | CA2721728A1 Treatment of inflammatory bowel disease with 6-mercaptopurine |
10/22/2009 | CA2721670A1 3-phenylpyrazolo[5,1-b]thiazole compound |
10/22/2009 | CA2721339A1 Activating agent for peroxisome proliferator activated receptor |
10/22/2009 | CA2721333A1 Novel lipid formulations for nucleic acid delivery |
10/21/2009 | EP2110384A1 Hepatopoietin and use thereof |
10/21/2009 | EP2110142A2 Inhibition of secretion from non-neuronal cells |
10/21/2009 | EP2110134A1 Cocoa extract compounds and methods for making and using the same |
10/21/2009 | EP2110133A1 Prophylactic and/or therapeutic agent for functional dyspepsia |
10/21/2009 | EP2110130A1 Pharmaceutical use of 6-mercaptopurine |
10/21/2009 | EP2110127A1 Hepatic Fibrosis Inhibitor |
10/21/2009 | EP2109615A1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators |
10/21/2009 | EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
10/21/2009 | EP1479300B1 Amino acid powder and process for producing the same |
10/21/2009 | EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
10/21/2009 | EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
10/21/2009 | EP1423413B1 Peptidic compounds selectively binding to p-selectin |
10/21/2009 | EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines |
10/21/2009 | EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors |
10/21/2009 | EP1371373B1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor |
10/21/2009 | EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
10/21/2009 | EP1169062B1 Heat stable coated colloidal iron oxides |
10/21/2009 | CN101563106A Combination of nmda- receptor ligand and a compound with 5-HT6 receptor affinity |
10/21/2009 | CN101563100A Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
10/21/2009 | CN101563092A A composition comprising the extract of combined herbs for preventing and treating liver disease |
10/21/2009 | CN101560523A Nutrient compound based on mixed fermented culture of five probiotics |
10/21/2009 | CN101560460A Health wine and preparing method thereof |
10/21/2009 | CN101560253A Method for the crystallization of human serum albumin |
10/21/2009 | CN101560248A Attenuated enterotoxin C2 superantigen mutant protein, preparation method and application thereof |
10/21/2009 | CN101560246A Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs |
10/21/2009 | CN101560161A New process for serial production of choline chloride aqueous solution agent |
10/21/2009 | CN101560126A Water-application quick floating oil pesticide and application method thereof |
10/21/2009 | CN101559230A Special solvent of lansoprazole lyophilized powder for injection |
10/21/2009 | CN101559226A Drug component for preventing and curing pig diarrhea |
10/21/2009 | CN101559217A Oral administration route of 7P peptide and application thereof to prevention or treatment of nephritis |
10/21/2009 | CN101559216A Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof |
10/21/2009 | CN101559205A Traditional Chinese medicine composition for curing chronic gastritis |
10/21/2009 | CN101559192A Traditional Chinese medicine granular formulation for warming stomach and regulating middle warmer and quality control method thereof |
10/21/2009 | CN101559165A Shengcao kidney-tonifying oral liquid |
10/21/2009 | CN101559150A Traditional Chinese medicine preparation for treating hepatitis B |
10/21/2009 | CN101559142A Chinese wolfberry health care medicinal white spirit |
10/21/2009 | CN101559140A Micelle solution for immune regulation |
10/21/2009 | CN101559137A Drug special for treating gastric diseases |
10/21/2009 | CN101559126A Component composition with effect on curing sore throat |
10/21/2009 | CN101559122A Traditional Chinese medicine composition for curing chronic colitis in external application mode |
10/21/2009 | CN101559110A Anti-tumor medicine anemonin as well as preparation method and application of composition thereof |
10/21/2009 | CN101559106A Medicament for treating gastritis |
10/21/2009 | CN101559100A Acesodyne capsule for heart and stomach |
10/21/2009 | CN101559088A Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide |
10/21/2009 | CN101559082A Method for preparing probiotic preparation for reducing blood lipid and adjusting intestinal flora |
10/21/2009 | CN101559078A Glue series medicine |